1.
Déo Malaquini LL, Rocha de Souza LF, Ebani Parada L, Gonçalves Grasso J, Hala Nunes NA. Risk-benefit of tirzepatide, semaglutide, and bariatric surgery in obesity. Interamerican Journal of Health Sciences [Internet]. 2025 Jan. 1 [cited 2025 Jan. 28];5:277. Available from: https://ijhsc.uai.edu.ar/index.php/ijhsc/article/view/277